ArticleFolia microbiologica2026
Antioxidant and antibacterial potency of Pleurotus citrinopileatus: by GC-MS characterization, bioactive compound profiling, synergy analysis, and In-Silico validation of microbial target interactions.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid development of antimicrobial resistance has intensified the demand for safe, multifunctional, and mechanistically validated natural antimicrobials beyond conventional antibiotics. Edible mushrooms, particularly Pleurotus species, represent an underexplored reservoir of bioactive metabolites; however, most studies remain limited to preliminary bioactivity screening without mechanistic confirmation. In this study, the antibacterial and antioxidant potential of Pleurotus citrinopileatus was systematically assessed through integrated experimental and in-silico methods. Aqueous (AEPC), ethanolic (EEPC), and methanolic (MEPC) extracts were subjected to GC-MS profiling, antioxidant assays, antibacterial activity, synergistic interaction study of Mushroom with plants, molecular docking, and 100-ns molecular dynamics (MD) simulations. GC-MS analysis identified 9, 19, and 25 bioactive compounds in AEPC, EEPC, and MEPC, respectively, with sterols such as ergosterol and cholesta-8,24-dien-3-ol predominating in MEPC. Methanolic extract exhibited the strongest antioxidant activity (91.18% DPPH scavenging; IC₅₀ ≈ 8 µL/mL), while EEPC demonstrated superior antibacterial efficacy, producing pronounced inhibition zones against Proteus vulgaris, Pseudomonas aeruginosa, and Staphylococcus aureus. All extracts showed bactericidal activity with MIC values ranging from 25-150 mg/mL and MBC/MIC ratios ≤ 2. Synergistic combinations with neem and tulsi enhanced antibacterial zones by 5-7 mm and increased antioxidant activity up to 92.28%. Molecular docking revealed strong binding affinities (- 7.2 to - 11.9 kcal/mol) of key sterols against multiple bacterial targets, comparable to ciprofloxacin, with ergosterol exhibiting the highest affinity toward P. aeruginosa alginate lyase. MD simulations confirmed the stability of protein-ligand complexes, supported by low RMSD, stable radius of gyration, and persistent hydrogen-bond interactions. Overall, P. citrinopileatus emerges as a promising natural reservoir of antibacterial and antioxidant agents, offering a synergistically enhanced, mechanistically validated strategy for combating pathogenic bacteria. These findings support the potential of Pleurotus citrinopileatus as a natural source of antioxidant and antibacterial agents, warranting further toxicological and in vivo investigations for therapeutic applications.
Indexed as
Identifiers
42479326What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.